ZM-447439
Catalog No. A11009
ZM 447439是Aurora A和Aurora B的选择性和ATP竞争性抑制剂,IC50分别为110 nM和130 nM。它对Aurora A/B的选择性是MEK1,Src,Lck的8倍以上,对CDK1/2/4,Plk1,Chk1等的影响很小。
Catalog Num | A11009 |
---|---|
M. Wt | 513.6 |
Formula | C29H31N5O4 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 331771-20-1 |
Synonyms | ZM447439 |
SMILES | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5 |
ZM 447439是Aurora A和Aurora B的选择性和ATP竞争性抑制剂,IC50分别为110 nM和130 nM。它对Aurora A/B的选择性是MEK1,Src,Lck的8倍以上,对CDK1/2/4,Plk1,Chk1等的影响很小。
Targets
Target | Value |
---|---|
AuroraA | IC50: 110nM |
AuroraB | IC50: 130nM |
LCK | IC50: 880nM |
Src | IC50: 1.03μM |
MEK1 | IC50: 1.79μM |
CDK1 | IC50: >10μM |
CDK2 | IC50: >10μM |
CDK4 | IC50: >10μM |
PLK1 | IC50: >10μM |
Chk1 | IC50: >10μM |
IKK1 | IC50: >10μM |
IKK2 | IC50: >10μM |
cFLT2 | IC50: >10μM |
KDR2 | IC50: >10μM |
ZAP70 | IC50: >10μM |
FAK | IC50: >10μM |
In vitro (25°C) | DMSO | 90 mg/mL (175.23 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.47 mL | 97.35 mL | 194.7 mL |
0.5 mM | 3.89 mL | 19.47 mL | 38.94 mL |
1 mM | 1.95 mL | 9.74 mL | 19.47 mL |
5 mM | 0.39 mL | 1.95 mL | 3.89 mL |
*The above data is based on the productmolecular weight 513.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.